ArticleJournal of animal science2025
Evaluating the inoculating bacterial communities within the bovine neonatal respiratory tract after applying an ablation technique to the dam vaginal microbiota prior to parturition.
Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The vaginal microbiota (VM) is the neonate's first microbial exposure, playing a role in early health outcomes. However, the impact of VM disruption at parturition on neonatal microbial inoculation and passive transfer success remains unclear. Betadine lavages (BL) are commonly used to control reproductive tract infections but can induce microbial dysbiosis. Disrupting the VM before calving may reduce microbial competition during colonization, increasing the risk of pathogen establishment. This study aimed to determine whether VM dysbiosis affects neonatal bacterial communities and passive transfer in beef cow-calf pairs. Cows (n = 12) were randomly assigned to a control group (CON) or BL treatment group (BLG) 2 wk before calving. BLG cows received 1 to 2 treatments based on calving date. Samples (dam colostrum, calf sera, dam-vaginal swab, dam-udder swab, dam-haircoat swab, and calf-nasal swab) were collected within 24 h of birth and stored at -80 °C. The V3-V4 region of the 16S rRNA gene was sequenced using Illumina MiSeq. Alpha diversity was assessed via 2-way ANOVA, β-diversity via PERMANOVA, and taxonomic differences via LEfSe. IgG concentrations in calf serum and colostrum were analyzed using ELISA. Data were evaluated using the R software package (v. 2023.03 + 386). BL-induced VM dysbiosis did not alter α-diversity in the dam-vaginal (P = 0.42), dam-udder (P = 0.53), or dam-haircoat (P = 0.21) microbiota but did affect the calf-nasal microbiota (P = 0.03). Beta diversity was unchanged in the dam-vaginal (P = 0.66) and dam-udder (P = 0.56) microbiota but trended toward greater variation in BLG calf-nasal (P = 0.08) and dam-haircoat (P = 0.09) samples. BLG calves exhibited an increased relative abundance of the phylum Actinobacteria and decreased relative abundance of the phylum Proteobacteria in the nasal microbiota compared with CON calves. Passive transfer status did not differ between groups (P = 0.88), but BLG dams had higher colostrum IgG concentrations than CON dams (P = 0.04), suggesting an immune response to pre-calving microbial disruption. Together, these results are indicative of microbial dysbiosis prior to parturition, leading to an increased immune response in BLG dams, which altered colostrum IgG. Thus, dam colostrum composition could drive immune responses against neonatal inoculating bacteria, resulting in differing nasal microbial communities between BLG and CON calves.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.